Institutional investors purchased a net $966.3 thousand shares of REGN during the quarter ended March 2015. This may signal that the smart money is gaining interest in this company as the 73.26% of shares outstanding that institutional investors hold is actually below the Biotechnology industry average.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
JANUS CAPITAL MANAGEMENT LLC Bought 1.1 Million shares of Regeneron Pharmaceuticals